Boston Scientific | BSX - Ebitda


Boston Scientific reported $1.63B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.63B 27M Jun/2026
CONMED USD 78.12M 21.73M Jun/2026
Cooper Companies USD 323.4M 13.2M Dec/2025
Danaher USD 1.84B 81M Jun/2026
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Globus Medical USD 231.83M 48.62M Mar/2026
Illumina USD 330M 80M Jun/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 75.63M 171.44M Mar/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025